Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 20:30 | 2026-03-10 | MDLN | Medline Inc. | Carlyle Group Inc. | 10% owner | Surgical & Medical Instruments & Apparatus | SALE | $41.00 | 26,105,840 | $1,070,339,440 | 127,567,724 | -17.0% |
| 2026-03-03 00:30 | 2026-02-26 | SARO | StandardAero, Inc. | Carlyle Group Inc. | 10% owner | Aircraft Engines & Engine Parts | SALE | $31.46 | 19,840,268 | $624,174,831 | 84,587,035 | -19.0% |
| 2026-01-31 00:30 | 2026-01-29 | SARO | StandardAero, Inc. | Carlyle Group Inc. | 10% owner | Aircraft Engines & Engine Parts | SALE | $31.00 | 48,246,588 | $1,495,644,228 | 104,427,303 | -31.6% |
| 2025-12-23 00:30 | 2025-12-18 | MDLN | Medline Inc. | Carlyle Group Inc. | 10% owner | Surgical & Medical Instruments & Apparatus | SALE | $29.00 | 19,136,333 | $554,953,657 | 145,924,924 | -11.6% |
| 2025-06-02 23:30 | 2025-05-29 | SARO | StandardAero, Inc. | Carlyle Group Inc. | 10% owner | Aircraft Engines & Engine Parts | SALE | $27.30 | 3,671,271 | $100,225,698 | 152,673,891 | -2.3% |
| 2025-05-28 23:30 | 2025-05-23 | SARO | StandardAero, Inc. | Carlyle Group Inc. | 10% owner | Aircraft Engines & Engine Parts | SALE | $27.30 | 24,475,138 | $668,171,267 | 156,345,162 | -13.5% |
| 2025-03-31 23:30 | 2025-03-27 | SARO | StandardAero, Inc. | Carlyle Group Inc. | 10% owner | Aircraft Engines & Engine Parts | SALE | $27.16 | 29,370,166 | $797,693,709 | 180,820,300 | -14.0% |
| 2024-12-05 00:30 | 2024-12-02 | CSLR | SunPower Inc. | Carlyle Group Inc. | 10% owner | Construction - Special Trade Contractors | SALE | $2.01 | 28,438 | $57,030 | 1,992,427 | -1.4% |
| 2024-12-03 05:13 | 2024-11-21 | CSLR | SunPower Inc. | Carlyle Group Inc. | 10% owner | Construction - Special Trade Contractors | SALE | $2.02 | 134,596 | $272,234 | 2,020,865 | -6.2% |
| 2024-11-22 01:08 | 2024-11-21 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $35.31 | 8,260,183 | $291,700,102 | 0 | -100.0% |
| 2024-10-22 00:09 | 2024-10-17 | CSLR | SunPower Inc. | Carlyle Group Inc. | 10% owner | Construction - Special Trade Contractors | SALE | $2.33 | 250,000 | $582,250 | 2,155,461 | -10.4% |
| 2024-10-17 23:30 | 2024-10-15 | CSLR | SunPower Inc. | Carlyle Group Inc. | 10% owner | Construction - Special Trade Contractors | SALE | $2.16 | 500,000 | $1,079,700 | 2,405,461 | -17.2% |
| 2024-10-15 23:30 | 2024-10-11 | CSLR | SunPower Inc. | Carlyle Group Inc. | 10% owner | Construction - Special Trade Contractors | SALE | $2.24 | 342,905 | $769,719 | 2,905,461 | -10.6% |
| 2024-10-11 23:30 | 2024-10-09 | CSLR | SunPower Inc. | Carlyle Group Inc. | 10% owner | Construction - Special Trade Contractors | SALE | $2.13 | 1,319,331 | $2,809,515 | 3,248,366 | -28.9% |
| 2024-10-09 23:30 | 2024-10-07 | CSLR | SunPower Inc. | Carlyle Group Inc. | 10% owner | Construction - Special Trade Contractors | SALE | $2.48 | 333,643 | $826,634 | 4,567,697 | -6.8% |
| 2024-10-07 23:30 | 2024-10-03 | SARO | StandardAero, Inc. | Carlyle Group Inc. | 10% owner | Aircraft Engines & Engine Parts | SALE | $22.74 | 12,849,448 | $292,196,448 | 210,190,466 | -5.8% |
| 2024-08-13 23:30 | 2024-08-09 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $41.53 | 74,134 | $3,078,978 | 8,260,183 | -0.9% |
| 2024-08-09 23:15 | 2024-08-07 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $40.59 | 184,885 | $7,505,277 | 8,334,317 | -2.2% |
| 2024-08-07 23:48 | 2024-07-18 | CSLR | SunPower Inc. | Carlyle Group Inc. | 10% owner | Construction - Special Trade Contractors | SALE | $1.40 | 35,143 | $49,200 | 4,901,340 | -0.7% |
| 2024-08-07 23:30 | 2024-08-05 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $40.31 | 205,144 | $8,270,114 | 8,519,202 | -2.4% |
| 2024-08-05 23:30 | 2024-08-01 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $41.76 | 404,402 | $16,888,272 | 8,724,346 | -4.4% |
| 2024-08-02 00:01 | 2024-07-30 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $39.41 | 315,467 | $12,432,838 | 9,128,748 | -3.3% |
| 2024-07-30 23:30 | 2024-07-26 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $38.93 | 262,016 | $10,200,545 | 9,444,215 | -2.7% |
| 2024-07-26 23:30 | 2024-07-24 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $38.72 | 621,541 | $24,064,389 | 9,706,231 | -6.0% |
| 2024-07-24 23:30 | 2024-07-22 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $35.82 | 234,786 | $8,411,161 | 10,327,772 | -2.2% |
| 2024-07-22 23:30 | 2024-07-18 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $34.13 | 167,506 | $5,716,360 | 10,562,558 | -1.6% |
| 2024-07-18 23:30 | 2024-07-16 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $33.85 | 164,498 | $5,568,965 | 10,730,064 | -1.5% |
| 2024-07-17 03:17 | 2024-07-12 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $31.95 | 150,440 | $4,806,498 | 10,894,562 | -1.4% |
| 2024-07-12 23:30 | 2024-07-10 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $31.12 | 120,968 | $3,764,028 | 11,045,002 | -1.1% |
| 2024-07-10 23:30 | 2024-07-08 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $30.30 | 83,754 | $2,537,822 | 11,165,970 | -0.7% |
| 2024-07-08 23:30 | 2024-07-03 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $31.01 | 103,463 | $3,208,067 | 11,249,724 | -0.9% |
| 2024-07-03 20:15 | 2024-07-01 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $31.77 | 167,564 | $5,323,659 | 11,353,187 | -1.5% |
| 2024-07-01 23:30 | 2024-06-27 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $33.27 | 96,317 | $3,204,650 | 11,520,751 | -0.8% |
| 2024-06-27 23:30 | 2024-06-25 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $33.11 | 148,954 | $4,931,882 | 11,617,068 | -1.3% |
| 2024-06-25 23:56 | 2024-06-21 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $34.69 | 142,293 | $4,936,173 | 11,766,022 | -1.2% |
| 2024-06-21 23:30 | 2024-06-18 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $35.34 | 115,748 | $4,090,222 | 11,908,315 | -1.0% |
| 2024-06-19 00:46 | 2024-06-14 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $36.10 | 227,623 | $8,218,010 | 12,024,063 | -1.9% |
| 2024-06-15 00:02 | 2024-06-12 | QDEL | QuidelOrtho Corp | Carlyle Group Inc. | 10% owner | In Vitro & In Vivo Diagnostic Substances | SALE | $38.46 | 208,497 | $8,018,461 | 12,251,686 | -1.7% |
| 2024-02-13 02:23 | 2024-02-08 | JSPR | Jasper Therapeutics, Inc. | Carlyle Group Inc. | Other | Biological Products, (No Diagnostic Substances) | BUY | $12.95 | 190,000 | $2,460,500 | 1,066,189 | +21.7% |
| 2023-05-10 23:37 | 2023-05-08 | MKSI | MKS INC | Carlyle Group Inc. | 10% owner | Industrial Instruments For Measurement, Display, and Control | SALE | $86.13 | 2,000,000 | $172,250,000 | 6,482,732 | -23.6% |
| 2023-02-01 01:24 | 2023-01-27 | JSPR | Jasper Therapeutics, Inc. | Carlyle Group Inc. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $1.50 | 3,133,333 | $4,700,000 | 8,761,891 | +55.7% |
| 2022-08-19 23:39 | 2022-08-17 | VERA | Vera Therapeutics, Inc. | Carlyle Group Inc. | 10% owner | Pharmaceutical Preparations | OPT+S | $20.25 | 9,925 | $201,026 | 2,960,231 | -0.3% |
| 2022-08-18 01:45 | 2022-08-15 | ZI | ZoomInfo Technologies Inc. | Carlyle Group Inc. | Other | Services-Prepackaged Software | SALE | $50.85 | 167,755 | $8,529,537 | 40,307,862 | -0.4% |
| 2022-08-16 01:24 | 2022-08-11 | ZI | ZoomInfo Technologies Inc. | Carlyle Group Inc. | 10% owner | Services-Prepackaged Software | SALE | $49.29 | 255,851 | $12,611,152 | 40,475,617 | -0.6% |
| 2022-08-11 23:30 | 2022-08-09 | ZI | ZoomInfo Technologies Inc. | Carlyle Group Inc. | 10% owner | Services-Prepackaged Software | SALE | $47.82 | 348,094 | $16,647,247 | 40,731,468 | -0.8% |
| 2022-08-09 23:32 | 2022-08-05 | ZI | ZoomInfo Technologies Inc. | Carlyle Group Inc. | 10% owner | Services-Prepackaged Software | SALE | $47.74 | 341,903 | $16,321,765 | 41,079,562 | -0.8% |
| 2022-08-05 23:30 | 2022-08-03 | ZI | ZoomInfo Technologies Inc. | Carlyle Group Inc. | 10% owner | Services-Prepackaged Software | SALE | $46.07 | 249,680 | $11,502,283 | 41,421,465 | -0.6% |
| 2022-04-23 00:25 | 2022-04-20 | ZI | ZoomInfo Technologies Inc. | Carlyle Group Inc. | 10% owner | Services-Prepackaged Software | SALE | $57.00 | 100 | $5,700 | 41,671,145 | 0.0% |
| 2022-04-15 23:30 | 2022-04-13 | ZI | ZoomInfo Technologies Inc. | Carlyle Group Inc. | 10% owner | Services-Prepackaged Software | SALE | $57.13 | 86,023 | $4,914,227 | 41,671,245 | -0.2% |
| 2022-04-12 00:11 | 2022-04-07 | ZI | ZoomInfo Technologies Inc. | Carlyle Group Inc. | 10% owner | Services-Prepackaged Software | SALE | $57.23 | 8,546 | $489,051 | 41,757,268 | 0.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.